- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02606981
Automatic Chlorination and Child Health in Urban Bangladesh
Evaluating Low-cost Automatic Water Disinfection Systems to Improve Water Quality and Child Health in Urban Bangladesh
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Investigators will conduct a blinded cluster randomized controlled trial to evaluate the health and economic impacts of having access to automatically chlorinated water. The unit of randomization will be shared water points that typically serve 20-200 households. Shared water points connected to holding tanks compatible with the water treatment technology, and serving more than 4 households with at least one child under five, will be identified. Households accessing eligible water points as their primary drinking water source will be enrolled before installation of chlorine devices, and a baseline survey will be conducted of water quality, diarrhea prevalence, and health care expenditures. Following this baseline, households will be randomly assigned to control or treatment groups. The chlorination devices will be installed at the treatment group water points, while a doser containing vitamin C (and no chlorine), will be installed in the control group. The free chlorine dosing target will be below <1ppm to preserve blinding. All households will be surveyed every 2-3 months for a total follow up period of 14-16 months (5-7 survey rounds, budget permitting).
Objectives:
- To evaluate the impact of an automated chlorination system on microbial stored drinking water quality, residual chlorine, user satisfaction, user perceptions of water taste and smell, under-five child diarrhea (longitudinal prevalence) compared to a control group.
- Compare the marginal additional cost (per person served) of installing and maintaining an automated chlorination system integrated with the current water supply infrastructure in low-income areas of Dhaka.
- Assess the impact of an automated chlorination system on hospital visits and health care expenditures.
- To measure secondary outcomes of the impact of an automated chlorination system including under-five child weight-for-age (WAZ), under-five height-for-age (HAZ), as well as levels of C-reactive protein and immunoglobin G in serum samples collected from children under five (these are objective indicators of infection, such as repeat diarrheal episodes).
Analysis:
The primary analyses will be intent-to-treat (investigators will analyze differences in outcomes between the treatment and control groups, with groups defined by their random allocation). Investigators will also conduct a secondary analysis comparing outcomes between intervention and control, where the intervention group is defined as those households that had free chlorine residual detected in their stored drinking water (treated on the treated analysis).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Gazipur
-
Tongi/Dhaka, Gazipur, Bangladesh
- Tongi and Dhaka Uddan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Households with at least one child under 60 months old
- Households using enrolled shared water point as primary drinking water source
Exclusion Criteria:
- Households with a private drinking water source
Note: New births and children under 60 months that migrate into compounds accessing the enrolled water points for drinking water will be enrolled into the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Chlorination
Device: Water chlorination by the Flogenic Primary drinking water source will be outfitted with automatic dosing device supplied with chlorine tablets.
The device is called the Flogenic.
|
The chlorine doser delivers a constant amount of chlorine into water as it flows into a holding tank.
The water is then piped to public and private taps.
Other Names:
|
|
PLACEBO_COMPARATOR: Control
Active control: Vitamin C dosing into water.
Primary drinking water source will be outfitted with automatic dosing device supplied with vitamin C tablets.
The device is not commercially available.
|
The control group will receive a vitamin C dosing device that looks identical to the intervention chlorine doser installed in the holding tank that feeds their shared water access point.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diarrhea longitudinal prevalence
Time Frame: Measured every 2-3 months for 16 months post baseline
|
1-week recall period, case definition is 3 or more loose/watery bowel movements in 24 hours
|
Measured every 2-3 months for 16 months post baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Weight-for-age-z-score
Time Frame: Measured every 2-3 months for 16 months post baseline
|
Weight-for-age z-score among children under five years
|
Measured every 2-3 months for 16 months post baseline
|
|
Height-for-age-z-score
Time Frame: Measured at baseline and 16 months after baseline
|
Height-for-age z-score among children under five
|
Measured at baseline and 16 months after baseline
|
|
Respiratory illness longitudinal prevalence
Time Frame: Measured every 2-3 months for 16 months post baseline
|
one week recall period, symptoms include congestion, cough, difficulty breathing
|
Measured every 2-3 months for 16 months post baseline
|
|
C-reactive protein
Time Frame: Measured at baseline and conclusion of study (16 months post baseline) among children under five
|
Measured at baseline and conclusion of study (16 months post baseline) among children under five
|
|
|
total immunoglobin G (IgG)
Time Frame: Measured at baseline and conclusion of study (16 months post baseline) among children under five
|
Measured at baseline and conclusion of study (16 months post baseline) among children under five
|
|
|
Prevalence and number of enteric pathogens
Time Frame: Measured 6-12 months after intervention delivery among children under five
|
Measured 6-12 months after intervention delivery among children under five
|
|
|
Caregiver defined diarrhea
Time Frame: Measured every 2-3 months for 16 months post baseline
|
1-week recall period, defined with local Bengali word for diarrhea
|
Measured every 2-3 months for 16 months post baseline
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Microbial water quality
Time Frame: Measured monthly among a subset of households, for 16 months post baseline
|
Colony forming units of the fecal indicator bacteria, E. coli
|
Measured monthly among a subset of households, for 16 months post baseline
|
|
Chlorine residual in household stored drinking water
Time Frame: Measured every 2-3 months for 16 months post baseline
|
Free chlorine residual in ppm
|
Measured every 2-3 months for 16 months post baseline
|
|
health related treatment and associated cost
Time Frame: Measured every 2-3 months for 16 months post baseline
|
Measured every 2-3 months for 16 months post baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Amy Pickering, PhD, Stanford University
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 30456
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Communicable Diseases
-
Deraya UniversityNot yet recruitingNon Communicable Diseases | Non Communicable Chronic DiseasesEgypt
-
Medical University of BialystokCompletedNon Communicable DiseasesPoland
-
Kaiser PermanenteUniversity of Colorado, DenverCompletedCommunicable DiseaseUnited States
-
Radboud University Medical CenterNational Institute for Public Health and the Environment (RIVM)CompletedInfectious and Communicable Diseases
-
Beijing Tsinghua Chang Gung HospitalRecruitingLifestyle Intervention | Non Communicable DiseasesChina
-
National Institute of Allergy and Infectious Diseases...CompletedCommunicable Diseases | Infection | Communicable Diseases, Emerging | Emerging Infectious DiseasesUnited States
-
Institut Louis MalardéInstitut Pasteur; Institut National en Santé Publique du Québec; Institut de... and other collaboratorsCompletedCommunicable Diseases | Microbiome | Non Communicable Diseases | Metal Poison | Pesticide Exposure | Genetics Population | CiguateraFrench Polynesia
-
Milton S. Hershey Medical CenterMerck Sharp & Dohme LLCCompletedVaccine Hesitancy | Communicable Diseases in ChildrenUnited States
-
Chi Research & Infotec Ltd.Directorate General of Health ServicesCompletedNon-communicable Disease Risk FactorsBangladesh
-
Chinese University of Hong KongCompletedHealth Risk Behaviors | Non Communicable DiseasesHong Kong
Clinical Trials on Water chlorination by the Flogenic
-
Jimma UniversityCompleted
-
Harvard UniversityYale UniversityCompletedMalnutrition | Dysentery | Social Transmission of Health BehaviorsUnited States
-
University of California, BerkeleyNational Institute of Allergy and Infectious Diseases (NIAID); Walter Reed... and other collaboratorsRecruitingClean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates (CLEAN)Sepsis | Antibiotic Resistant Infection | Serious Bacterial Infection | Neonatal Mortality | Enteric InfectionsKenya, United States
-
Swiss Tropical & Public Health InstituteUniversity of Applied Sciences and Arts Northwestern Switzerland; Terre des... and other collaboratorsCompletedHand Hygiene | Well-Being | Handwashing BehaviourNigeria, Palestinian Territory, occupied
-
University of OttawaRecruitingHyperthermia | Aging | Heat Acclimation and Thermotolerance | ThermoregulationCanada
-
University of Rome Tor VergataCompletedIncident Cases of Lung Cancer (Code ICD-O C340-C349)Italy
-
University of Roma La SapienzaNot yet recruitingKnee Osteoarthritis
-
University of Roma La SapienzaUniversità degli studi di Roma Foro ItalicoEnrolling by invitationWounds and Injuries | Wound Healing | Wound - in Medical Care | Venous Ulcers | Ulcers | Wound Care | Wound CleansingItaly
-
Sun JiaRecruiting
-
Pharos University in AlexandriaActive, not recruiting